Literature DB >> 30536016

Predicting PD-1/PD-L1 status in bladder cancer with 18F-FDG PET?

Emily B Ehlerding1, Xiaoli Lan2,3, Weibo Cai4.   

Abstract

Entities:  

Year:  2018        PMID： 30536016      PMCID： PMC6451660          DOI： 10.1007/s00259-018-4224-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  16 in total

Review 1.  Classifying Cancers Based on T-cell Infiltration and PD-L1.

Authors:  Michele W L Teng; Shin Foong Ngiow; Antoni Ribas; Mark J Smyth
Journal:  Cancer Res       Date:  2015-06-01       Impact factor: 12.701

2.  Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.

Authors:  Xiang Zhou; Ruohua Chen; Wenhui Xie; Yicheng Ni; Jianjun Liu; Gang Huang
Journal:  J Nucl Med       Date:  2014-10-23       Impact factor: 10.057

3.  Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.

Authors:  Ruohua Chen; Xiang Zhou; Jianjun Liu; Gang Huang
Journal:  J Nucl Med       Date:  2016-03-10       Impact factor: 10.057

4.  Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.

Authors:  Benjamin M Larimer; Eric Wehrenberg-Klee; Frank Dubois; Anila Mehta; Taylor Kalomeris; Keith Flaherty; Genevieve Boland; Umar Mahmood
Journal:  Cancer Res       Date:  2017-05-01       Impact factor: 12.701

5.  Fructose-1,6-Bisphosphatase 1 Reduces 18F FDG Uptake in Hepatocellular Carcinoma.

Authors:  Ruohua Chen; Jiajin Li; Xiang Zhou; Jianjun Liu; Gang Huang
Journal:  Radiology       Date:  2017-04-06       Impact factor: 11.105

Review 6.  Molecular Imaging of Immunotherapy Targets in Cancer.

Authors:  Emily B Ehlerding; Christopher G England; Douglas G McNeel; Weibo Cai
Journal:  J Nucl Med       Date:  2016-07-28       Impact factor: 10.057

7.  Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.

Authors:  Egesta Lopci; Luca Toschi; Fabio Grizzi; Daoud Rahal; Laura Olivari; Giovanni Francesco Castino; Silvia Marchetti; Nina Cortese; Dorina Qehajaj; Daniela Pistillo; Marco Alloisio; Massimo Roncalli; Paola Allavena; Armando Santoro; Federica Marchesi; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-01       Impact factor: 9.236

Review 8.  Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.

Authors:  Jing Liu; Min Dong; Xiaorong Sun; Wenwu Li; Ligang Xing; Jinming Yu
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

9.  Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.

Authors:  Mohammad Rashidian; Jessica R Ingram; Michael Dougan; Anushka Dongre; Katherine A Whang; Camille LeGall; Juan J Cragnolini; Brian Bierie; Monica Gostissa; James Gorman; Gijsbert M Grotenbreg; Atul Bhan; Robert A Weinberg; Hidde L Ploegh
Journal:  J Exp Med       Date:  2017-06-30       Impact factor: 14.307

10.  Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer.

Authors:  Julienne L Carstens; Pedro Correa de Sampaio; Dalu Yang; Souptik Barua; Huamin Wang; Arvind Rao; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Nat Commun       Date:  2017-04-27       Impact factor: 14.919
View more
  1 in total

1.  Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers.

Authors:  Qingzhu Liu; Lei Jiang; Ke Li; Hang Li; Gaochao Lv; Jianguo Lin; Ling Qiu
Journal:  Cancer Immunol Immunother       Date:  2021-01-02       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.